Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 140

1.

Use of eptifibatide as a bridge antiplatelet agent for intrathecal drug delivery system placement.

Sisk J, Palma M, Cooper C, Eltahawy E, Atallah J.

Pain Physician. 2012 Nov-Dec;15(6):479-83.

PMID:
23159964
[PubMed - indexed for MEDLINE]
Free Article
2.

Prolonged infusion of eptifibatide as bridge therapy between bare-metal stent insertion and cardiovascular surgery: case report and review of the literature.

Pickett AM, Taylor DA, Ackman ML.

Pharmacotherapy. 2010 Apr;30(4):127e-33e. doi: 10.1592/phco.30.4.420. Review.

PMID:
20334463
[PubMed - indexed for MEDLINE]
3.

Safety of high-dose intravenous eptifibatide as an adjunct to internal carotid artery angioplasty and stent placement: a prospective registry.

Qureshi AI, Siddiqui AM, Hanel RA, Xavier AR, Kim SH, Kirmani JF, Boulos AS, Hopkins LN.

Neurosurgery. 2004 Feb;54(2):307-16; discussion 316-7.

PMID:
14744276
[PubMed - indexed for MEDLINE]
4.

Left main stent thrombosis complicated by eptifibatide-induced acute thrombocytopenia.

Yang EH, Perez E, Zhiroff KA, Burstein S.

Tex Heart Inst J. 2011;38(2):174-8.

PMID:
21494531
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Clopidogrel loading with eptifibatide to arrest the reactivity of platelets: results of the Clopidogrel Loading With Eptifibatide to Arrest the Reactivity of Platelets (CLEAR PLATELETS) study.

Gurbel PA, Bliden KP, Zaman KA, Yoho JA, Hayes KM, Tantry US.

Circulation. 2005 Mar 8;111(9):1153-9. Epub 2005 Feb 28.

PMID:
15738352
[PubMed - indexed for MEDLINE]
Free Article
6.

Bridging therapy after recent stent implantation: case report and review of data.

Wessler JD, Saldana F, Giugliano RP.

Cardiovasc Revasc Med. 2012 Jan-Feb;13(1):30-8. doi: 10.1016/j.carrev.2011.08.004. Epub 2011 Oct 21.

PMID:
22019210
[PubMed - indexed for MEDLINE]
7.

Perioperative management of a neurosurgical patient requiring antiplatelet therapy.

Than KD, Rohatgi P, Wilson TJ, Gregory Thompson B.

J Clin Neurosci. 2012 Sep;19(9):1316-20. doi: 10.1016/j.jocn.2011.12.018. Epub 2012 Jul 10.

PMID:
22784876
[PubMed - indexed for MEDLINE]
8.

A randomized trial comparing eptifibatide vs. placebo in patients with diffuse coronary artery disease undergoing drug-eluting stent implantation: design of the INtegrilin plus STenting to Avoid myocardial Necrosis Trial.

Biondi-Zoccai GG, Valgimigli M, Sheiban I, Margheri M, Marzocchi A, Prati F, Vischi M, Lettieri C, Violini R, Sardella G, Stabile A, Clementi F, Romeo F, Colombo A, Sangiorgi G.

J Cardiovasc Med (Hagerstown). 2008 Sep;9(9):957-62. doi: 10.2459/JCM.0b013e3282ffd3a6.

PMID:
18695440
[PubMed - indexed for MEDLINE]
10.

Clinical pharmacology of eptifibatide.

Phillips DR, Scarborough RM.

Am J Cardiol. 1997 Aug 18;80(4A):11B-20B. Review.

PMID:
9291241
[PubMed - indexed for MEDLINE]
11.

Rebound platelet activation after termination of prasugrel and aspirin therapy due to confirmed non-compliance in patient enrolled in the JUMBO Trial.

Serebruany VL, Midei MG, Meilman H, Malinin AI, Lowry DR.

Int J Clin Pract. 2006 Jul;60(7):863-6.

PMID:
16846403
[PubMed - indexed for MEDLINE]
12.

Bridging with glycoprotein IIb/IIIa inhibitors for periprocedural management of antiplatelet therapy in patients with drug eluting stents.

Ben Morrison T, Horst BM, Brown MJ, Bell MR, Daniels PR.

Catheter Cardiovasc Interv. 2012 Mar 1;79(4):575-82.

PMID:
22448399
[PubMed - indexed for MEDLINE]
13.

Therapeutic use of intravenous eptifibatide in patients undergoing percutaneous coronary intervention: acute coronary syndromes and elective stenting.

Granada JF, Kleiman NS.

Am J Cardiovasc Drugs. 2004;4(1):31-41. Review.

PMID:
14967064
[PubMed - indexed for MEDLINE]
14.

Platelet inhibition with prasugrel (CS-747) compared with clopidogrel in patients undergoing coronary stenting: the subset from the JUMBO study.

Serebruany VL, Midei MG, Meilman H, Malinin AI, Lowry DR.

Postgrad Med J. 2006 Jun;82(968):404-10.

PMID:
16754711
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Eptifibatide provides additional platelet inhibition in non-ST-elevation myocardial infarction patients already treated with aspirin and clopidogrel. Results of the platelet activity extinction in non-Q-wave myocardial infarction with aspirin, clopidogrel, and eptifibatide (PEACE) study.

Dalby M, Montalescot G, Bal dit Sollier C, Vicaut E, Soulat T, Collet JP, Choussat R, Gallois V, Drobinski G, Drouet L, Thomas D.

J Am Coll Cardiol. 2004 Jan 21;43(2):162-8.

PMID:
14736431
[PubMed - indexed for MEDLINE]
Free Article
16.

Eptifibatide-eluting stent as an antiproliferative and antithrombotic agent: in vitro evaluation.

Chitkara K, Hogrefe K, Vasa-Nicotera M, Swanson N, Gershlick AH.

J Invasive Cardiol. 2006 Sep;18(9):417-22.

PMID:
16954580
[PubMed - indexed for MEDLINE]
17.

Open-label phase I clinical study to assess the safety of intravenous eptifibatide in patients undergoing internal carotid artery angioplasty and stent placement.

Qureshi AI, Ali Z, Suri MF, Kim SH, Fessler RD, Ringer AJ, Guterman LR, Hopkins LN.

Neurosurgery. 2001 May;48(5):998-1004; discussion 1004-5.

PMID:
11334301
[PubMed - indexed for MEDLINE]
18.

Safety of glycoprotein IIb-IIIa inhibitors: A heart surgeon's perspective.

Dyke CM.

Am Heart J. 1999 Oct;138(4 Pt 2):307-16. Review.

PMID:
10502236
[PubMed - indexed for MEDLINE]
19.

Long-term efficacy of platelet glycoprotein IIb/IIIa integrin blockade with eptifibatide in coronary stent intervention.

O'Shea JC, Buller CE, Cantor WJ, Chandler AB, Cohen EA, Cohen DJ, Gilchrist IC, Kleiman NS, Labinaz M, Madan M, Hafley GE, Califf RM, Kitt MM, Strony J, Tcheng JE; ESPRIT Investigators.

JAMA. 2002 Feb 6;287(5):618-21.

PMID:
11829701
[PubMed - indexed for MEDLINE]
20.

Comparison of one-year outcomes following coronary artery stenting in diabetic versus nondiabetic patients (from the Enhanced Suppression of the Platelet IIb/IIIa Receptor With Integrilin Therapy [ESPRIT] Trial).

Labinaz M, Madan M, O'Shea JO, Kilaru R, Chin W, Pieper K, McGuire DK, Saucedo JF, Talley JD, Lui H, Kitt MM, Califf RM, Tcheng JT; ESPRIT Investigators.

Am J Cardiol. 2002 Sep 15;90(6):585-90.

PMID:
12231081
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk